Login
$DNTH
$89.20 -$0.35 (0.39%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Marino Garcia Also a director
Director, President and Chief Executive Officer
59 Since 2021
5 years
$10,614,702
Edward Carr
Senior Vice President, Chief Accounting Officer
56 Since 2022
4 years
Not reported
Ryan Savitz
EVP, CFO & CBO
Title from the Form 4 dated Nov 9, 2026
37 Not stated $5,074,953
Adam Veness
SVP, General Counsel and Sec.
Title from the Form 4 dated Aug 13, 2026
40 Not stated Not reported
Simrat Randhawa
EVP, Head of R&D
Title from the Form 4 dated Sep 1, 2026
56 Not stated $5,221,537

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
4.1 years
from year joined
CEO also chairs the board
No
Alison F. Lawton
Director Age On board Independent Committees Other public boards 2025 pay Source
Alison F. Lawton
64 2020
6 years
Independent
Nominating and Corporate Governance Committee · Chair
ProQR Therapeutics N.V. (Nasdaq: PRQR) $259,787
Marino Garcia
59 2021
5 years
Not independent None stated None stated Paid as CEO
Sujay Kango
62 2025
1 year
Independent
Compensation Committee
None stated $418,860
Anne McGeorge
65 2019
7 years
Independent
Audit Committee · Chair Nominating and Corporate Governance Committee
The Oncology Institute, Inc. (Nasdaq: TOI) $232,382
Jonathan Violin, Ph.D.
50 2019
7 years
Independent
Science and Technology Committee
None stated $217,476
Paula Soteropoulos
58 2022
4 years
Independent
Audit Committee Compensation Committee · Chair
Rallybio Corporation (Nasdaq: RLYB) $231,787
Simon Read, Ph.D.
55 2025
1 year
Independent
Nominating and Corporate Governance Committee Science and Technology Committee
None stated $382,309
Steven Romano, M.D.
66 2024
2 years
Independent
Compensation Committee Science and Technology Committee · Chair
None stated $225,647

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 9, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support